Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus

• Status: Completed
• Trial end date: 2018-01-20
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine wether coenzyme Q10 is effective in reducing markers of endothelial dysfunction in pediatric patients with type 1 diabetes mellitus and aslo to investigate its effect on glycemic control and lipid profile of those patients and its effect on patient's quality of life.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Coenzyme Q10; Insulin; Insulin, Globin Zinc; Ubiquinone

Criteria

Inclusion Criteria:

1. Age: patients from 8 to 18 years old.

2. Outpatient with at least 1 year history of type 1 diabetes mellitus.

3. Insulin requirement of more than or equal 0.5 U/Kg/day.

4. Approval to participate and give informed consent.

Exclusion Criteria:

1. Presence of systemic disorders such as celiac disease, hypothyroidism or hyperthyroidism.

2. Preexisting cardiovascular disease or hypertension.

3. Chronic kidney disease or chronic liver disease.

4. Significant mental illness.

5. Intake of other antioxidants such as ascorbic acid and α-tocopherol and omega3 supplement within the last 3 months.

6. Intake of coenzyme Q10 within the last 3 months.